Dr. Michael E. Meininger, MD

Dr. Meininger practices at Northern New Jersey Center for Advanced Endoscopy in Englewood Cliffs, New Jersey.

Dr. Meininger's NPI, 1174567010, was assigned on June 15, 2006. Dr. Meininger graduated from New York University Grossman School of Medicine in 1996. Dr. Meininger holds New Jersey license 25MA07341400.

Dr. Meininger's primary practice is Northern New Jersey Center for Advanced Endoscopy, at 270 Sylvan Avenue, Suite 100, Englewood Cliffs, NJ 07632. The practice phone is (201) 408-5505.

Dr. Meininger's primary practice is Northern New Jersey Center for Advanced Endoscopy in Englewood Cliffs, New Jersey. Dr. Meininger is also affiliated with Englewood Hospital. The medical group on file is Allied Digestive Health. Dmand AI also links Dr. Meininger to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meininger practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Meininger's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Meininger is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Meininger is licensed in New Jersey.

CMS data shows 1,213 Medicare services from Dr. Meininger across 12 procedure codes in 2024, for 648 Medicare patients. Medicare paid $128,592 for them.

CMS counts 648 Medicare patients who saw Dr. Meininger in 2024. The largest group is 65 to 74, with 293 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meininger's median patient age at 59, with 53% women.

In 2024, Dr. Meininger wrote 1,082 Medicare Part D claims for 405 patients. 80% of them were for generic drugs. CMS names the drug for 810 of them, across 20 drugs with 11 or more claims each, at $88,673 in total drug cost. In 2023, CMS named 831 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Meininger for performance year 2024, reported as part of a group. Dr. Meininger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meininger as offering telehealth. CMS counts 99 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Meininger, more than 76% of the clinicians it reports for that procedure.

CMS Open Payments shows 741 general payments to Dr. Meininger from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,148.

Dr. Meininger graduated from New York University Grossman School of Medicine in 1996.